Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Grapefruit Benefits

PharmAthene Submits Proposal To BARDA In Response To Broad Agency Announcement For Advanced Research And Development For Valortim(R)
PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced that it has submitted a proposal to the Biomedical Advanced Research and Development Authority (BARDA) in response to a Broad Agency Announcement (BAA-BARDA-09-34) for advanced research and development of medical countermeasures for chemical, biological, radiological and nuclear threats. PharmAthene has requested funding to further develop Valortim(R), a fully human monoclonal antibody, for the prevention and treatment of anthrax infection. To date, the Company has received funding commitments from the U. S. government totaling up to $24 million to advance the development of Valortim(R).
generic viagra online
A Bidirectional Relationship Between Chronic Stress And Sleep Problems shown by study
According to a research abstract that will be presented on Wednesday, June 10, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, people with chronic stress report shorter sleep duration, worse sleep quality, and more daytime functioning impairments. Conversely, daytime functioning impairments and shorter sleep duration demonstrated a predictive relationship with habitual stress complaints.
News of the day
Maine Fights For Senators' Votes, Grassley Can't Satisfy Either Side
Senators home for the Fourth of July recess found activists on each side of the health care debate waiting for them.
Mental Health

Oncology Conference

Individuals interested in cancer research and disease management are invited to attend the 26th International Conference entitled, "Advances in the Applications of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells." This interdisciplinary conference is considered a keynote event in the biomedical research and biopharmaceutical industry. The event will take place June 22-24, 2009 at the Corfu Holiday Palace in Corfu, Greece, and will feature interactive presentations, unique open air workshops and expert discussions led by key opinion leaders in the field. Attendees will learn about the latest research developments and emerging cancer therapies. Natural Standard


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009